Trial Profile
Phase III trial of CCX-140 in patients with diabetic nephropathy
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 24 Mar 2015
Price :
$35
*
At a glance
- Drugs Ilacirnon (Primary)
- Indications Diabetic nephropathies
- Focus Adverse reactions; Therapeutic Use
- 24 Mar 2015 New trial record